Less Invasive, More Precise: The Shift in Colorectal Cancer Care
In an exclusive interview at WHX Dubai 2026, Dr. Julio Garcia-Aguilar, Chief…
FDA Grants Breakthrough Therapy Designation to Novartis’ Ianalumab for Sjögren’s Disease
The FDA has granted Breakthrough Therapy designation to Novartis’ ianalumab for Sjögren’s…
Breast Cancer: What you need to know
Breast cancer is a prevalent disease that affects millions worldwide. Understanding its…
Amgen’s Cancer Therapy Meets Key Goal in Phase 3 Gastric Cancer Study
Amgen announced the Phase 3 FORTITUDE-101 clinical trial evaluating first-line bemarituzumab plus chemotherapy (mFOLFOX6)…
Datroway: A Novel TROP2‑Directed Therapy Approved for Lung Cancer
AstraZeneca and Daiichi Sankyo’s new antibody drug conjugate, Datroway (datopotamab deruxtecan), has received accelerated…
